Company Directory
PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!
As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.
To add your organisation to the directory, simply register as a contributor and add your organisation's details. You can also upgrade to a premium listing for only £500/year, this offers even greater scope for added content (more photos, more links, more copy), and even more exposure.
Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site.
Working for pharmaceutical and biotechnology companies, Aspire Scientific is an independent medical writing agency led by experienced editorial team members. Our aim is simple: to take the pressure off our clients by consistently delivering high-quality medical writing projects on time, and with meticulous levels of service.
Astex is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the central nervous system (CNS). We are a member of one of Japan’s leading pharmaceutical companies, the Otsuka group, and therefore benefit from the resources and commitment of a global pharmaceutical company.
We are an instrumental partner for our Life Sciences clients, by bringing them creative recruitment solutions from early product development to manufacturing & commercialization. This is complemented by our team’s cumulated expertise and experience in strategy & operational consulting services, which gives us a highly qualitative approach.
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells.
Our experienced Leadership Team and international Board of Directors have deep roots in the pharmaceutical industry and ambitious plans to develop and commercialize products that can improve the lives of patients, by providing clinicians with safe and effective treatments at cost-effective prices.
Atlas is a state-of-the-art 503B facility built with ISO 5 class hoods, ISO 7 class clean rooms and 24/7 environmental monitoring with high efficiency particulate air quality. We leverage 17 years of compounding expertise and quality processing to deliver the highest level of patient care and patient safety possible for each and every product we deliver.
We are a biopharmaceutical company specifically pioneering the development of host-targeting antiviral therapies set up by a team of leading scientists in viral research and seasoned industry experts. The Company aims to develop new antiviral therapies against different severe respiratory viral infections with a high unmet medical need.
Aucta Pharmaceuticals, Inc. (AUCTA, Latin-improved, enhanced) is a technology based company focusing on the development and commercialization of Branded Specialty Products. Aucta is a pharmaceutical company creating better products of proven molecules using 505(b)(2) regulatory pathway.
We focus on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT) and other neuromuscular diseases. The company is rooted in the ground-breaking research at VIB and KU Leuven and supported by V-Bio Ventures, PMV, Advent France Biotechnology and Gemma Frisius Fund.
Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer.
Avania is a leading, global full-service contract research organization focused on the management of clinical studies for medical devices, IVDs, biologics, and device-drug combination products internationally. Avania supports products from the first-in-human phase through the post-market phase with the same customized approach.
Avidity Biosciences is pioneering a new class of oligonucleotide-based therapies called AOCs designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases.
